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Abstract
Introduction: New techniques for the percutaneous treatment of coronary chronic total 
occlusions (CTO) have had a high success rate since a few years ago, so the interest for this 
treatment has been increasing these days.
Methods: The current observational study was performed in Modarres hospital as a 
tertiary referral center. All the patients with documented stable angina who had failed 
to response to full guideline-mediated medical therapy, referred to our hospital, were 
candidates for coronary angiography. Antegrade strategy was applied for all these patients. 
The length of the lesion, the fluoroscopy time of the CTO angioplasty, consumed contrast 
volume, the number of guide wires used, whether a corsair or tornus micro-catheter was 
used or not, and the success rate of the angioplasty were documented for further analysis.
Results: A total of 47 patients with documented stable angina were finally included. The 
median age was 59 (45-78) and 70.2% were male. The mean length of the lesion was 
34.0 ± 1.1 .The mean fluoroscopy time and contrast volume were 57.9 ± 3.2 minutes and 
525.9 ± 20.9 mL, respectively. In average, 2.2 guide wires were used. Corsair and tornus 
micro-catheters were applied in 30 (63.8%) and 5 (10.6%) of the cases, respectively. 
Seven complications (all including coronary dissection) occurred. In-hospital major 
adverse cardiac events (MACE) rate was 10.6%, all of which were non-Q wave myocardial 
infarction. The success rate was 85.1%. The higher number of used wires, use of corsair, 
and tornus micro-catheter were not significantly concordant with success rate (P-value > 
0.05); in addition, longer lesions was not concordant with unsuccessfulness rate (P-value 
> 0.05).
Conclusions: Patient selection for CTO-angioplasty should be performed more carefully. 
Patients’ quality of life and risk of probable procedural complications and future cardiac 
events should be assessed to decide the best treatment approach. Radiation exposure, 
contrast consumption and fluoroscopy time are recommended to be monitored during 
the procedure and thresholds should be defined to enhance safety and efficacy.
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Coronary chronic total occlusions (CTOs) are described by 
substantial atherosclerotic plaque burden within the artery, 
due to complete obstruction of the vessel. While the period 
of occlusion is challenging to define on clinical fields, a total 
occlusion should be present for at least three months to be 
delineated a proper CTO [1]. The presence of a CTO is one 
of the most frequent aims for Coronary artery bypass grafting 
(CABG) referral. Percutaneous coronary intervention (PCI) 
of chronic total occlusions has traditionally been restricted 
by technical success rates of 50% to 70%, despite being ac-
complished in greatly selected cases [2, 3].
New techniques and devices increase the interest for the per-
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cutaneous treatment of coronary CTOs with a higher success 
rate than a few years ago. Percutaneous treatment for these 
lesions improves the symptoms and prognosis of patients in 
the stable phase of coronary disease. Current advances in in-
terventional guide wires, catheters, and innovative methods 
have resulted in noteworthy progresses in success ratios with 
percutaneous coronary intervention [4-6]. In the present ob-
servational study, we explain our experiences in CTO PCI in 
a single center of PCI and describe data in a two-year period.
METHODS
The current observational study was performed in Modarres 
hospital as a tertiary referral center from September 2013 to 
December 2015. All the patients with documented stable 
angina who had failed to response to full guideline-mediat-
ed medical therapy, referred to our hospital, were candidates 
for coronary angiography. In addition, every patient with 
any type of acute coronary syndrome was excluded from the 
study. Standard angiography was conducted in an elective 
state for patients with femoral approach and if the angiogra-
phy revealed CTO lesion criteria in one vessel territory, those 
cases were considered as final included patients in the study. 
The Institutional Review Board approved the study protocol 
and patients provided informed written consents.
Antegrade strategy was applied for all the patients. Length 
of the lesion, fluoroscopy time of the CTO angioplasty, con-
sumed contrast volume, the number of guide wires used, 
whether or not corsair or tornus micro-catheter was used, 
and the success rate of the angioplasty were documented for 
further analysis. SPSS statistical software version 20.0 for 
windows (SPSS Inc., Chicago, IL) was applied. Independent 
sample t-test was used for quantitative studies. P values less 
than 0.05 were considered statistically remarkable.
RESULTS
A total of 47 patients with documented chronic stable angi-
na were finally included. The median age was 59 (45-78) and 
70.2% of patients were male. All the lesions were type C with 
pre-procedure TIMI flow grade 0. The mean length of the le-
sion was 34.0 ± 1.1 .The mean fluoroscopy time and contrast 
volume were 57.9 ± 3.2 minutes and 525.9 ± 20.9 mL, respec-
tively. In average, 2.2 (2-4) guide wires were used. Corsair 
and tornus micro-catheters were applied in 30 (63.8%) and 5 
(10.6%) cases, respectively. Seven complications (all includ-
ing coronary artery dissection) occurred. In-hospital major 
adverse cardiac events (MACE) rate was 10.6%, all of which 
were non-Q wave myocardial infarction. All the results are 
shown in Table 1. The success rate was 85.1%. Higher num-
ber of used wires, use of corsair, and tornus micro-catheter 
were not significantly concordant with success rate (P-value 
> 0.05); in addition, longer lesions was not concordant with 
unsuccessfulness rate (P-value > 0.05) (Table 1).
DISCUSSION
Improvement in symptoms, enhancement in left ventricular 
function, and increase in survival are the potential benefits of 
CTO PCI [3]. PCI for CTO is associated with a substantial 
use of laboratory catheterization supplies. Moreover, proce-
dure and fluoroscopic times double, as time-consuming as 
those for PCI for non-CTO lesions; CTO PCI can also re-
sult in improvident use of laboratory catheterization supplies 
and interventionists time, which can reduce the patient flow 
through the laboratory [7]. Furthermore, the extent of equip-
ment required for successful achievement of the process can 
be more than that of standard PCI, because interventionists 
will often need multiple guiding catheters, guide wires and 
other devices to execute the procedure [8].
The risk of radiation injury and contrast nephropathy poten-
tially affect CTO-angioplasty. In our center, the mean fluo-
roscopy time of 57.9 ± 3.2 minutes and contrast volume of 
525.9 ± 20.9 mL were relatively higher than the average CTO 
angioplasty in other centers, which should be considered in 
further procedures to be reduced [9, 10]. The rate of com-
plications and in-hospital major cardiac events in our center 
were comparable with other centers’ results [9, 11, 12]. Cor-
onary dissection consisted of all the CTO-angioplasties in 
our center.
Table1: Results of CTO-angioplasty with Ante Grade Approach
Characteristics N = 47
Mean age 59 (45-78)
Sex (male) 32 (70.2)
Mean fluoroscopy time (minutes) 57.9 ± 3.2




Number of guide-wires used 2.2 (2- 4)
Use of Corsair micro catheter 30 (63.8)
Use of Tonus micro catheter 5 (10.6)
Left coronary guiding catheter
Extra backup (XB) 44 (93.6)
Left Amplatz 2 (4.3)
Left Judkins 1 (2.1)
Right coronary guiding catheter
Left Amplatz 46 (97.9)
Right Judkins 1 (2.1)
Success rate 40 (85.1)
In-hospital MACE* 5 (10.6)
Complications** 5 (10.6)
Values are presented as No (%), mean (range) and mean ± SD.
MACE: major adverse cardiac events
*All were non-Wave MI
**All were coronary artery dissection
Considerable scholar and economic resources have been 
provided in the effort to conquer the complexity in cross-
ing CTOs with a wire. Special new designed wires and tech-
niques have been explained. A range of devices have been 
demonstrated in an effort to overcome wire-crossing com-
plexity [13-15]; however, as a vague result, use of corsair or 
tornus micro-catheter were not significantly concordant with 
success rate in our observational study; although, we should 
judge about this result with caution because of our relatively 
small sample size. While the antegrade strategy was applied 
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for all the patients in our study, the success rate was relative-
ly prominent. CTO PCI is speedily developing into its own 
field of interventional cardiology. Improving success neces-
sitates long-term promise to master the extensive variety of 
accessible techniques, each of which may offer the only way 
to success in distinct cases.
Our study was a single center study. As it is known, CTO an-
gioplasty is less popular in comparison with CABG of these 
lesions, even regarding some escalation in trends to CTO-
PCI in recent years. This study could be considered as a pi-
lot study and a new window for future large and multicenter 
studies, which will reveal more detailed results. Moreover, 
valuable clinical and systematic reviews could be published 
from results of various centers. It is recommended for future 
large sample-size studies to have long duration follow-ups.
Treatment of CTO lesions has developed in recent years as a 
consequence of a rebellion in medical equipment, which fa-
cilitates these patients to be treated with success rates higher 
than a few years ago. However, patient selection for CTO-an-
gioplasty should be performed more carefully. Patients’ qual-
ity of life and risk of probable procedural complications and 
future cardiac events should be assessed to decide the best 
treatment approach. Radiation exposure, contrast consump-
tion and fluoroscopy time are recommended to be moni-
tored during the procedure and thresholds should be defined 
to enhance safety and efficacy.
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